<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08904121810536</udiDi>
    <basicUdiDi>B-08904121810536</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0032</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:59.770Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810529</udiDi>
    <basicUdiDi>B-08904121810529</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7532</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:57.373Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810512</udiDi>
    <basicUdiDi>B-08904121810512</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5032</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:53.771Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810505</udiDi>
    <basicUdiDi>B-08904121810505</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2532</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:51.377Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810499</udiDi>
    <basicUdiDi>B-08904121810499</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0032</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:50.184Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810482</udiDi>
    <basicUdiDi>B-08904121810482</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5029</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:47.772Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810475</udiDi>
    <basicUdiDi>B-08904121810475</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0029</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:44.171Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810468</udiDi>
    <basicUdiDi>B-08904121810468</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5029</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:41.766Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810451</udiDi>
    <basicUdiDi>B-08904121810451</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0029</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:40.575Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810444</udiDi>
    <basicUdiDi>B-08904121810444</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7529</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:38.158Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810437</udiDi>
    <basicUdiDi>B-08904121810437</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5029</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:34.557Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810420</udiDi>
    <basicUdiDi>B-08904121810420</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2529</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:32.163Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810413</udiDi>
    <basicUdiDi>B-08904121810413</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0029</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:30.956Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810406</udiDi>
    <basicUdiDi>B-08904121810406</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5024</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:28.566Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810390</udiDi>
    <basicUdiDi>B-08904121810390</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0024</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:24.948Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810383</udiDi>
    <basicUdiDi>B-08904121810383</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5024</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:22.545Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810376</udiDi>
    <basicUdiDi>B-08904121810376</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0024</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:21.345Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810369</udiDi>
    <basicUdiDi>B-08904121810369</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7524</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:18.947Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810352</udiDi>
    <basicUdiDi>B-08904121810352</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5024</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:15.370Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810345</udiDi>
    <basicUdiDi>B-08904121810345</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2524</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:12.959Z</lastUpdated>
  </row>
</eudamedExport>